Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Carbapenem-resistant Acinetobacter baumannii complex in the United States—An epidemiological and molecular description of isolates collected through the Emerging Infections Program, 2019

American Journal of Infection Control(2024)10.1016/j.ajic.2024.04.184Source: DataRank Database

Carbapenem-resistant Acinetobacter baumannii complex in the United States—An epidemiological and molecular description of isolates collected through the Emerging Infections Program, 2019 is a research paper published in American Journal of Infection Control (2024). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 2.14)OA: hybridTopics (59)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (33)

Davina Campbell ORCID,Susannah L. McKay ORCID,Nicholas Vlachos,Alex B. Burgin ORCID,Mark Burroughs ORCID

Live enrichment

PubMed:38692307 OpenAlex:https://openalex.org/W4396216562

Centers for Disease Control and Prevention

Grant: CDC-RFA-CK17-1701

Intramural CDC HHS

Grant: CC999999

FWCI

2.14

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttp://www.ajicjournal.org/article/S0196655324004589/pdf

publisherhttp://www.ajicjournal.org/article/S0196655324004589/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0196655324004589?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0196655324004589?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ajic.2024.04.184

Fields of Study

Antibiotic Resistance in BacteriaAntibiotic Use and ResistanceInfections and bacterial resistanceHumansAcinetobacter baumanniiUnited StatesAcinetobacter InfectionsMaleCarbapenemsMiddle AgedAgedFemaleAnti-Bacterial AgentsMicrobial Sensitivity TestsAdultAged, 80 and overWhole Genome Sequencingbeta-LactamasesCommunicable Diseases, EmergingYoung AdultBacterial Proteins

MeSH Terms

Whole Genome SequencingAcinetobacter InfectionsAdultAgedAged, 80 and overAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedUnited StatesCarbapenemsCommunicable Diseases, EmergingAcinetobacter baumanniiYoung Adult

Keywords

Acinetobacter baumanniiMedicineEpidemiologyInfection controlMolecular epidemiologyCarbapenemPublic healthEnvironmental healthMicrobiologyIntensive care medicineAntibioticsInternal medicineBacteriaBiologyPseudomonas aeruginosaPathologyGeneticsGeneAntimicrobial drug resistanceSurveillance

Sustainable Development Goals

SDG 0: Good health and well-being